PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India. Electronic address: anantmohan@yahoo.com.\', \'Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Ocular Pharmacology, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Onco-Anesthesia, Pain and Palliative Care, All India Institute of Medical Sciences, New Delhi, India.\', \'Mahajan Laboratory, New Delhi, India.\', \'Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00239-710.1016/j.jiac.2021.08.021
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34483029
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all